These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7286033)

  • 61. [Evaluation of preincisional mexiletine administration to alleviate postoperative pain].
    Morita H; Higashizawa T; Yuasa H; Hiramatsu K; Koga Y
    Masui; 1998 Nov; 47(11):1311-4. PubMed ID: 9852693
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparative trial of mexiletine and lignocaine in the treatment of early ventricular tachyarrhythmias after acute myocardial infarction.
    Horowitz JD; Anavekar SN; Morris PM; Goble AJ; Doyle AE; Louis WJ
    J Cardiovasc Pharmacol; 1981; 3(3):409-19. PubMed ID: 6168823
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative antidysrhythmic and haemodynamic effects of orally or intravenously administered mexiletine and ORG 6001 in the anaesthetized rat.
    Marshall RJ; Muir AW; Winslow E
    Br J Pharmacol; 1981 Oct; 74(2):381-8. PubMed ID: 7317687
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Determination of mexiletine in biological fluids by high-performance liquid chromatography.
    Breithaupt H; Wilfling M
    J Chromatogr; 1982 Jun; 230(1):97-105. PubMed ID: 7107772
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High-performance liquid chromatographic method for the measurement of mexiletine and flecainide in blood plasma or serum.
    Bhamra RK; Flanagan RJ; Holt DW
    J Chromatogr; 1984 May; 307(2):439-44. PubMed ID: 6736191
    [No Abstract]   [Full Text] [Related]  

  • 66. Cirrhosis of the liver markedly impairs the elimination of mexiletine.
    Pentikäinen PJ; Hietakorpi S; Halinen MO; Lampinen LM
    Eur J Clin Pharmacol; 1986; 30(1):83-8. PubMed ID: 3709636
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Baseline pharmacology, electrophysiology and pharmacokinetics of mexiletine.
    Middleton D
    Acta Cardiol Suppl; 1980; (25):45-53. PubMed ID: 6990666
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Liquid chromatographic determination of mexiletine and tocainide in human plasma with fluorescence detection after reaction with a modified o-phthalaldehyde reagent.
    Gupta RN; Lew M
    J Chromatogr; 1985 Nov; 344():221-30. PubMed ID: 3936856
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hemodynamic effects of an intravenous injection of mexiletine in patients hospitalised in intensive care units.
    Henrard L; Carlier J
    Acta Cardiol Suppl; 1980; (25):101-7. PubMed ID: 6966451
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Short-term myocardial uptake of lidocaine and mexiletine in patients with ischemic heart disease.
    Horowitz JD; Dynon MK; Woodward E; Sia ST; Macdonald PS; Morgan DJ; Goble AJ; Louis WJ
    Circulation; 1986 May; 73(5):987-96. PubMed ID: 3698242
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term clinical experience with mexiletine.
    Johansson BW; Stavenow L; Hanson A
    Am Heart J; 1984 May; 107(5 Pt 2):1099-102. PubMed ID: 6720535
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High pressure liquid chromatographic assay for mexiletine in serum.
    Grech-Bélanger O; Turgeon J; Gilbert M
    J Chromatogr Sci; 1984 Nov; 22(11):490-2. PubMed ID: 6501531
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mexiletine disposition: individual variation in response to urine acidification and alkalinisation.
    Mitchell BG; Clements JA; Pottage A; Prescott LF
    Br J Clin Pharmacol; 1983 Sep; 16(3):281-4. PubMed ID: 6626420
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings.
    Labbé L; O'Hara G; Lefebvre M; Lessard E; Gilbert M; Adedoyin A; Champagne J; Hamelin B; Turgeon J
    Clin Pharmacol Ther; 2000 Jul; 68(1):44-57. PubMed ID: 10945315
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Oral maintenance treatment with mexiletine after acute administration of xilocaine (author's transl)].
    Codecà L; Gruppillo P; Padovan GC; Masoni C; Masoni A
    G Ital Cardiol; 1981; 11(4):481-4. PubMed ID: 6169579
    [No Abstract]   [Full Text] [Related]  

  • 76. Gas chromatographic method for the routine serum monitoring of mexiletine.
    Grech-Bélanger O
    J Chromatogr; 1984 Jul; 309(1):165-9. PubMed ID: 6480762
    [No Abstract]   [Full Text] [Related]  

  • 77. Pharmacokinetics and absolute bioavailability of intramuscular tranexamic acid in man.
    Puigdellívol E; Carral ME; Moreno J; Plà-Delfina JM; Jané F
    Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):298-301. PubMed ID: 4018929
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Blood level of mexiletine in liver-damaged patients].
    Winter M; Brunner H; Horwatitsch H; Grabner G
    Adv Clin Pharmacol; 1978; 16():29-32. PubMed ID: 685749
    [No Abstract]   [Full Text] [Related]  

  • 79. Antiarrhythmic efficacy of combined intravenous and oral mexiletine in acute myocardial infarction. A double blind placebo-controlled study.
    Halinen MO; Pentikäinen PJ; Helin MJ; Rehnberg S
    Eur Heart J; 1984 Aug; 5(8):675-83. PubMed ID: 6383836
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The bioavailability of orphenadrine hydrochloride after intramuscular and oral administration.
    Rutigliano G; Labout JJ
    J Int Med Res; 1982; 10(6):447-50. PubMed ID: 7152086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.